GLP-1 and amylin receptor multiagonism with amycretin for obesity management.
Saved in:
| Title: | GLP-1 and amylin receptor multiagonism with amycretin for obesity management. |
|---|---|
| Authors: | Khoo B; Endocrinology, Division of Medicine, University College London, London, UK., Tan TM; Department of Metabolism, Digestion and Reproduction, Imperial College London, London W12 0HS, UK. Electronic address: t.tan@imperial.ac.uk. |
| Source: | Lancet (London, England) [Lancet] 2025 Jul 12; Vol. 406 (10499), pp. 104-106. Date of Electronic Publication: 2025 Jun 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1474-547X |
|---|---|
| DOI: | 10.1016/S0140-6736(25)01250-4 |
